FR2716196B1 - Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique. - Google Patents

Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.

Info

Publication number
FR2716196B1
FR2716196B1 FR9401738A FR9401738A FR2716196B1 FR 2716196 B1 FR2716196 B1 FR 2716196B1 FR 9401738 A FR9401738 A FR 9401738A FR 9401738 A FR9401738 A FR 9401738A FR 2716196 B1 FR2716196 B1 FR 2716196B1
Authority
FR
France
Prior art keywords
tetrazol
phenyl
preparation
therapeutic use
quinoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9401738A
Other languages
English (en)
Other versions
FR2716196A1 (fr
Inventor
Marc Daumas
Christian Hoornaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9401738A priority Critical patent/FR2716196B1/fr
Publication of FR2716196A1 publication Critical patent/FR2716196A1/fr
Application granted granted Critical
Publication of FR2716196B1 publication Critical patent/FR2716196B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9401738A 1994-02-16 1994-02-16 Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique. Expired - Fee Related FR2716196B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9401738A FR2716196B1 (fr) 1994-02-16 1994-02-16 Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401738A FR2716196B1 (fr) 1994-02-16 1994-02-16 Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.

Publications (2)

Publication Number Publication Date
FR2716196A1 FR2716196A1 (fr) 1995-08-18
FR2716196B1 true FR2716196B1 (fr) 1996-04-05

Family

ID=9460125

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9401738A Expired - Fee Related FR2716196B1 (fr) 1994-02-16 1994-02-16 Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.

Country Status (1)

Country Link
FR (1) FR2716196B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
ES2142817T3 (es) * 1991-12-27 2000-05-01 Kyowa Hakko Kogyo Kk Compuestos triciclicos como antagonistas de la angiotensina ii.
US5478832A (en) * 1992-05-08 1995-12-26 The Green Cross Corporation Quinoline compounds
FR2693197B1 (fr) * 1992-07-03 1994-09-23 Synthelabo Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
FR2699174B1 (fr) * 1992-12-14 1995-01-20 Synthelabo Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
FR2716196A1 (fr) 1995-08-18

Similar Documents

Publication Publication Date Title
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
FR2786770B1 (fr) Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
FR2710915B1 (fr) Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
FR2804430B1 (fr) Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2809730B1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
NO307930B1 (no) Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
DZ1718A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
ATE184005T1 (de) Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
FR2716196B1 (fr) Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.
FR2699920B1 (fr) Dérivés d'imidazo [2,1-b] benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique.
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2716193B1 (fr) Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.
FR2714055B1 (fr) Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique.
FI962994A0 (fi) Uusia leukotrieeni B4-johdoksia, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FR2792634B1 (fr) Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2666582B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique.
FR2703355B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
FR2699534B1 (fr) Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
FR2718442B1 (fr) Dérivés de 5-(1H-imidazol-4-yl)-1-oxopentylpipéridine, leur préparation et leur application en thérapeutique.
FR2717479B1 (fr) Nouvelles 3-(omega-benzoylpipéridino) alcoyl)-4H-Benzopyran-4-ones, leur préparation et leur application en thérapeutique.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20051031